Giuseppe Santabarbara

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With <i>RAS</i> Wild-type Metastatic Colorectal Cancer

Erika Martinelli, Giulia Martini, Vincenzo Famiglietti et al. · JAMA Oncology · 2021 · 185 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy

Giuseppe Santabarbara, Paolo Maione, Antônio Rossi et al. · Expert Opinion on Pharmacotherapy · 2015 · 58 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Valorization of Olive Mill Wastewater by Membrane Processes to Recover Natural Antioxidant Compounds for Cosmeceutical and Nutraceutical Applications or Functional Foods

Alberto Alfano, Luisana Corsuto, Rosario Finamore et al. · Antioxidants · 2018 · 52 citations · Full text

Engineering, Biochemistry, Environmental Engineering +17

Serum Vascular Endothelial Growth Factor (VEGF) Levels Correlate with Tumor VEGF and p53 Overexpression in Endocrine Positive Primary Breast Cancer

Francesco Iovino, Francesca Ferraraccio, Michele Orditura et al. · Cancer Investigation · 2008 · 27 citations

Medicine, Cancer Biology, Oncology +17

397O Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study

Erika Martinelli, Giulia Martini, Teresa Troiani et al. · Annals of Oncology · 2020 · 23 citations

Medicine, Oncology, Pharmacology +12